- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Plymouth Meeting Today
By the People, for the People
INOVIO to Participate in Upcoming Scientific Conference
Biotech company to showcase latest advancements at major industry event.
Apr. 1, 2026 at 4:55pm
Got story updates? Submit your updates here. ›
INOVIO, a biotechnology company based in Plymouth Meeting, Pennsylvania, has announced that it will participate in an upcoming scientific conference to showcase its latest advancements in the field.
Why it matters
As a leading player in the biotech industry, INOVIO's participation in this high-profile conference will allow the company to share its innovative research and technologies with the scientific community, potentially leading to new collaborations, investments, or breakthroughs.
The details
INOVIO, a publicly-traded biotechnology company, will be presenting its latest research and product developments at the upcoming conference. The event is expected to draw thousands of scientists, researchers, and industry leaders from around the world.
- The conference will take place from April 15-18, 2026.
The players
INOVIO
A biotechnology company that focuses on developing DNA medicines to treat and prevent infectious diseases and cancer.
What’s next
Following the conference, INOVIO plans to provide updates on any new partnerships, funding, or research breakthroughs that emerge from its participation.
The takeaway
INOVIO's presence at this major scientific conference underscores the company's commitment to advancing its innovative DNA medicine technologies and collaborating with the broader biotech community.
